Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Telephone enhancement of long-term engagement (TELE) in continuing care for substance abuse treatment: a NIDA clinical trials network (CTN) study.

Hubbard RL, Leimberger JD, Haynes L, Patkar AA, Holter J, Liepman MR, Lucas K, Tyson B, Day T, Thorpe EA, Faulkner B, Hasson A; National Institute on Drug Abuse.

Am J Addict. 2007 Nov-Dec;16(6):495-502.

PMID:
18058417
2.

Treatment programs in the National Drug Abuse Treatment Clinical Trials Network.

McCarty D, Fuller B, Kaskutas LA, Wendt WW, Nunes EV, Miller M, Forman R, Magruder KM, Arfken C, Copersino M, Floyd A, Sindelar J, Edmundson E.

Drug Alcohol Depend. 2008 Jan 1;92(1-3):200-7. Epub 2007 Sep 17.

3.

Systematic review identifies number of strategies important for retaining study participants.

Robinson KA, Dennison CR, Wayman DM, Pronovost PJ, Needham DM.

J Clin Epidemiol. 2007 Aug;60(8):757-65. Epub 2007 May 10. Review.

4.

Enhancing adherence among older African American men enrolled in a longitudinal cancer screening trial.

Ford ME, Havstad S, Vernon SW, Davis SD, Kroll D, Lamerato L, Swanson GM.

Gerontologist. 2006 Aug;46(4):545-50.

PMID:
16921009
5.

Enacting a theory of caring to recruit and retain vulnerable participants for sensitive research.

Kavanaugh K, Moro TT, Savage T, Mehendale R.

Res Nurs Health. 2006 Jun;29(3):244-52. Review.

6.

Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.

Peirce JM, Petry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, Schwartz M, Krasnansky J, Pencer E, Silva-Vazquez L, Kirby KC, Royer-Malvestuto C, Roll JM, Cohen A, Copersino ML, Kolodner K, Li R.

Arch Gen Psychiatry. 2006 Feb;63(2):201-8.

PMID:
16461864
7.

Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.

Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R.

Arch Gen Psychiatry. 2005 Oct;62(10):1148-56.

PMID:
16203960
8.

Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study.

Carroll KM, Ball SA, Nich C, Martino S, Frankforter TL, Farentinos C, Kunkel LE, Mikulich-Gilbertson SK, Morgenstern J, Obert JL, Polcin D, Snead N, Woody GE; National Institute on Drug Abuse Clinical Trials Network.

Drug Alcohol Depend. 2006 Feb 28;81(3):301-12. Epub 2005 Sep 28.

9.

A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network.

Ling W, Amass L, Shoptaw S, Annon JJ, Hillhouse M, Babcock D, Brigham G, Harrer J, Reid M, Muir J, Buchan B, Orr D, Woody G, Krejci J, Ziedonis D; Buprenorphine Study Protocol Group.

Addiction. 2005 Aug;100(8):1090-100. Erratum in: Addiction. 2006 Sep;101(9):1374.

10.

"I will miss the study, God bless you all": participation in a nutritional chemoprevention trial.

Moreno-Black G, Shor-Posner G, Miguez MJ, Burbano X, O'Mellan S, Yovanoff P.

Ethn Dis. 2004 Autumn;14(4):469-75.

PMID:
15724764
11.

Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.

Amass L, Ling W, Freese TE, Reiber C, Annon JJ, Cohen AJ, McCarty D, Reid MS, Brown LS, Clark C, Ziedonis DM, Krejci J, Stine S, Winhusen T, Brigham G, Babcock D, Muir JA, Buchan BJ, Horton T.

Am J Addict. 2004;13 Suppl 1:S42-66.

12.

Ethnic differences in substance abuse treatment retention, compliance, and outcome from two clinical trials.

Milligan CO, Nich C, Carroll KM.

Psychiatr Serv. 2004 Feb;55(2):167-73. Erratum in: Psychiatr Serv. 2004 Nov;55(11):1298.

13.

Challenges of recruitment and retention in multisite clinical research.

Cooley ME, Sarna L, Brown JK, Williams RD, Chernecky C, Padilla G, Danao LL.

Cancer Nurs. 2003 Oct;26(5):376-84; quiz 385-6.

PMID:
14710799
14.

Planning strategies for the avoidance of pitfalls in intervention research.

Pruitt RH, Privette AB.

J Adv Nurs. 2001 Aug;35(4):514-20. Review.

PMID:
11529950
15.

Recruitment and retention of elderly patients in clinical trials: issues and strategies.

Cassidy EL, Baird E, Sheikh JI.

Am J Geriatr Psychiatry. 2001 Spring;9(2):136-40.

PMID:
11316617
16.

Recruiting African Americans into research on cognitive aging.

McDougall GJ, Holston EC, Wilke P.

Ethn Dis. 2001 Winter;11(1):124-33.

17.

Predictors of substance abuse treatment retention among women and men in an HMO.

Mertens JR, Weisner CM.

Alcohol Clin Exp Res. 2000 Oct;24(10):1525-33.

PMID:
11045861
18.

Recruiting and retaining research participants for a clinical intervention study.

Grant JS, DePew DD.

J Neurosci Nurs. 1999 Dec;31(6):357-62. Review.

PMID:
10726244
19.

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.

Gail MH, Costantino JP, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V.

J Natl Cancer Inst. 1999 Nov 3;91(21):1829-46. Review. Erratum in: J Natl Cancer Inst 2000 Feb 2;92(3):275.

PMID:
10547390
20.

A retrospective investigation of an intensive outpatient substance abuse treatment program.

Fishman J, Reynolds T, Riedel E.

Am J Drug Alcohol Abuse. 1999 May;25(2):185-96.

PMID:
10395154

Supplemental Content

Support Center